- Home
- VRDN vs LNN Comparison
VRDN vs LNN Comparison
Compare VRDN & LNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRDN
- LNN
- Stock Information
- Founded
- VRDN 2006
- LNN 1954
- Country
- VRDN United States
- LNN United States
- Employees
- VRDN N/A
- LNN N/A
- Industry
- VRDN Medical Specialities
- LNN Industrial Machinery/Components
- Sector
- VRDN Health Care
- LNN Industrials
- Exchange
- VRDN Nasdaq
- LNN Nasdaq
- Market Cap
- VRDN 1.6B
- LNN 1.5B
- IPO Year
- VRDN N/A
- LNN 1988
- Fundamental
- Price
- VRDN $21.65
- LNN $141.53
- Analyst Decision
- VRDN Strong Buy
- LNN Hold
- Analyst Count
- VRDN 11
- LNN 1
- Target Price
- VRDN $38.80
- LNN $136.00
- AVG Volume (30 Days)
- VRDN 658.9K
- LNN 106.9K
- Earning Date
- VRDN 11-11-2025
- LNN 10-23-2025
- Dividend Yield
- VRDN N/A
- LNN 1.02%
- EPS Growth
- VRDN N/A
- LNN 5.71
- EPS
- VRDN N/A
- LNN 6.96
- Revenue
- VRDN $305,000.00
- LNN $677,807,000.00
- Revenue This Year
- VRDN N/A
- LNN $13.09
- Revenue Next Year
- VRDN $34,076.08
- LNN N/A
- P/E Ratio
- VRDN N/A
- LNN $20.39
- Revenue Growth
- VRDN 5.90
- LNN 9.46
- 52 Week Low
- VRDN $9.90
- LNN $112.14
- 52 Week High
- VRDN $27.20
- LNN $150.96
- Technical
- Relative Strength Index (RSI)
- VRDN 66.74
- LNN 56.04
- Support Level
- VRDN $20.83
- LNN $139.06
- Resistance Level
- VRDN $19.97
- LNN $141.54
- Average True Range (ATR)
- VRDN 0.92
- LNN 2.55
- MACD
- VRDN 0.18
- LNN 0.20
- Stochastic Oscillator
- VRDN 91.56
- LNN 73.19
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).
About LNN Lindsay Corporation
Lindsay Corp provides various proprietary water management and road infrastructure products and services. It has operations categorized into two main reporting segments: Irrigation, and Infrastructure. The company generates maximum revenue from the Irrigation segment. Its Irrigation segment includes manufacturing and marketing center pivot, lateral move, and hose reel irrigation systems, as well as various technology solutions such as GPS positioning and guidance, variable rate irrigation, wireless irrigation management, M2M communication technology, and smartphone applications. Geographically, it derives a majority of its revenue from the United States.